Combination with Methotrexate and Cyclophosphamide Attenuated Maturation of Dendritic Cells: Inducing Treg Skewing and Th17 Suppression In Vivo

Table 1

BMDC surface antigen’s expression of OVA group compared with control.

Group	𝑛	BMDC surface antigen’s expression (𝑋±𝑆, %)
		CD11c	CD40	CD80	CD86	MHC-II
Control	6	82.57±4.57	61.57±3.50	81.90±3.79	67.18±3.21	70.30±2.33
OVA Group	6	87.85±4.51	69.72±4.70^∗	89.78±3.67^∗	79.37±3.60^∗	84.32±2.81^∗

Values are expressed as mean ± standard deviation; t-test was used for statistical analysis.
^∗𝑃<0.05 was considered as statistically significant.